Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase

Endocrinology

Volumn 145, Issue 6, 2004, Pages 2978-2987

  Zahradka, Peter ^a,b,c   Litchie, Brenda ^a   Storie, Ben ^a   Helwer, Gail ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c St Boniface Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,1 DIMETHYLETHYL) 1 (4 METHYLPHENYL) 1H PYRAZOLO[3,4]PYRIMIDIN 4 AMINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANTIBODY; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P130; PROTEIN P70; PROTEIN P85; PROTEIN TYROSINE KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME ACTIVITY; INCUBATION TIME; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANGIOTENSIN II; ANIMALS; ANTIBODIES; CELL MOVEMENT; CELLS, CULTURED; ENZYME ACTIVATION; ENZYME INHIBITORS; INSULIN-LIKE GROWTH FACTOR I; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SWINE; TRANS-ACTIVATION (GENETICS);

EID: 2542464026     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0029     Document Type: Article

References (62)

1. Touyz RM, Schiffrin EL 2000 Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672
2. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B 1989 Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem 264:526-530
3. Molloy CJ, Taylor DS, Weber H 1993 Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem 268:7338-7345
4. Marrero MB, Schieffer B, Paxton WG, Duff JL, Berk BC, Bernstein KE 1995 The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovasc Res 30:530-536
5. Leduc I, Haddad P, Giasson E, Meloche S 1995 Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Mol Pharmacol 48:582-592
6. Paxton WG, Marrero MB, Klein JD, Delafontaine P, Berk BC, Bernstein KE 1994 The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem Biophys Res Commun 200:260-267
7. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC 1995 Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 77:1053-1059
8. Leduc I, Meloche S 1995 Angiotensin II stimulates tyrosine phosphorylation of the focal adhesion-associated protein paxillin in aortic smooth muscle cells. J Biol Chem 270:4401-4404
9. Li X, Earp HS 1997 Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells. J Biol Chem 272:14341-14348
10. Zhu T, Goh EL, LeRoith D, Lobie PE 1998 Growth hormone stimulates the formation of a multiprotein signaling complex involving p130(Cas) and CrkII. Resultant activation of c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK). J Biol Chem 273:33864-33875
11. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J 1995 Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376:737-745
12. Graves LM, He Y, Lambert J, Hunter D, Li X, Earp HS 1997 An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells. J Biol Chem 272:1920-1928
13. Voisin L, Foisy S, Giasson E, Lambert C, Moreau P, Meloche S 2002 EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors. Am J Physiol Cell Physiol 283:C446-C455
14. Kim S, Zhan Y, Izumi Y, Yasumoto H, Yano M, Iwao H 2000 In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Arterioscler Thromb Vasc Biol 20:2539-2545
15. Mondorf UF, Geiger H, Herrero M, Zeuzem S, Piiper A 2000 Involvement of the platelet-derived growth factor receptor in angiotensin II-induced activation of extracellular regulated kinases 1 and 2 in human mesangial cells. FEBS Lett 472:129-132
16. Du J, Sperling LS, Marrero MB, Phillips L, Delafontaine P 1996 G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-1 and insulin-like growth factor 1 receptor. Biochem Biophys Res Commun 218:934-939
17. Ali MS, Schieffer B, Delafontaine P, Bernstein KE, Ling BN, Marrero MB 1997 Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells. J Biol Chem 272:12373-12379
18. Saward L, Zahradka P 1997 Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81:249-257
19. Vanhaesebroeck B, Waterfield MD 1999 Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253:239-254
20. Yoshizumi M, Tsuchiya K, Kirima K, Kyaw M, Suzaki Y, Tamaki T 2001 Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells. Mol Pharmacol 60:656-665
21. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR 1996 Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93:12490-12495
22. Saward L, Zahradka P 1997 Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem 176:53-59
23. Yau L, Lukes H, McDiarmid H, Werner J, Zahradka P 1999 Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation. Eur J Biochem 266:1147-1157
24. Yau L, Litchie B, Thomas S, Storie B, Yurkova N, Zahradka P 2003 Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression. Eur J Biochem 270:101-110
25. Bornfeldt KE, Gidlof RA, Wasteson A, Lake M, Skottner A, Arnqvist HJ 1991 Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 34:307-313
26. Lee PD, Hintz RL, Rosenfeld RG, Benitz WE 1988 Presence of insulinlike growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells. In Vitro Cell Dev Biol 24:921-926
27. Davies SP, Reddy H, Caivano M, Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
28. Herbert JM, Augereau JM, Gleye J, Maffrand JP 1990 Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172:993-999
29. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA 1996 Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 271:695-701
30. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T 1998 Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273:8890-8896
31. Bokemeyer D, Schmitz U, Kramer HJ 2000 Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor. Kidney Int 58:549-558
32. Luttrell LM 2002 Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Can J Physiol Pharmacol 80:375-382
33. Russell WE, Van Wyk JJ, Pledger WJ 1984 Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci USA 81:2389-2392
34. Rohlik QT, Adams D, Kull Jr FC, Jacobs S 1987 An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun 149:276-281
35. Kovalenko M, Gazit A, Bohmer A, Rorsman C, Ronnstrand L, Heldin CH, Waltenberger J, Bohmer FD, Levitzki A 1994 Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation. Cancer Res 54:6106-6114
36. Levitzki A, Gazit A 1995 Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788
37. Blum G, Gazit A, Levitzki A 2000 Substrate competitive inhibitors of IGF-I receptor kinase. Biochemistry 39:15705-15712
38. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D 1997 Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 138:1427-1433
39. Saperstein R, Vicario PP, Strout HV, Brady E, Slater EE, Greenlee WJ, Ondeyka DL, Patchett AA, Hangauer DG 1989 Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cells. Biochemistry 28:5694-5701
40. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD 2001 Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535-602
41. Yau L, Zahradka P 1997 Immunodetection of activated mitogen-activated protein kinase in vascular tissues. Mol Cell Biochem 172:59-66
42. Hayashi K, Saga H, Chimori Y, Kimura K, Yamanaka Y, Sobue K 1998 Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase. J Biol Chem 273:28860-28867
43. Yin G, Yan C, Berk BC 2003 Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 35:780-783
44. Daub H, Weiss FU, Wallasch C, Ullrich A 1996 Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557-560
45. Marinissen MJ, Gutkind JS 2001 G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22:368-376
46. Saito Y, Berk BC 2001 Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J Mol Cell Cardiol 33:3-7
47. Eguchi S, Inagami T 2000 Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91:13-20
48. Crowley ST, Ray CJ, Nawaz D, Majack RA, Horwitz LD 1995 Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am J Physiol 269:H1641-H1647
49. Linseman DA, Benjamin CW, Jones DA 1995 Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 270:12563-12568
50. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T 1999 Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274:36843-36851
51. Eguchi S, Dempsey PJ, Frank GD, Motley ED, Inagami T 2001 Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease- dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276:7957-7962
52. Delafontaine P, Meng XP, Ku L, Du J 1995 Regulation of vascular smooth muscle cell insulin-like growth factor I receptors by phosphorothioate oligonucleotides. Effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression. J Biol Chem 270:14383-14388
53. Baserga R 1992 IGF-I receptor as the restriction point of the cell cycle. Ann NY Acad Sci 663:154-157
54. Brink M, Chrast J, Price SR, Mitch WE, Delafontaine P 1999 Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake. Hypertension 34:1053-1059
55. Luttrell LM, Della Rocca GJ, van Biesen T, Luttrell DK, Lefkowitz RJ 1997 Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J Biol Chem 272:4637-4644
56. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ 1999 c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274:8335-8343
57. Wu W, Graves LM, Gill GN, Parsons SJ, Samet JM 2002 Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation. J Biol Chem 277:24252-24257
58. Seta K, Sadoshima J 2003 Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem 278:9019-9026
59. Heuss C, Gerber U 2000 G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci 23:469-475
60. Weng YI, Shukla SD 2002 Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepatocytes. Biochim Biophys Acta 1589:285-297
61. Touyz RM, He G, Wu XH, Park JB, Mabrouk ME, Schiffrin EL 2001 Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 38:56-64
62. Ishida M, Ishida T, Thomas SM, Berk BC 1998 Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 82:7-12